13F HOLDINGS REPORT
CAXTON CORP
Quarter ended Q3 2023 · Filed August 14, 2023 · Accession 0000919574-23-004721
Total Value
$34.7M
Positions
7
Other Managers
0
Confidential Omitted
Yes
Holdings (7)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SAVARA INC | SVRA | 4,980,804 | $16.0M | 46.25% |
| 2 | XERIS BIOPHARMA HOLDINGS INC | XERS | 5,641,920 | $14.8M | 42.66% |
| 3 | REZOLUTE INC | RZLT | 1,318,967 | $2.6M | 7.54% |
| 4 | MOLECULAR TEMPLATES INC | 608550109 | 2,052,991 | $985,436 | 2.84% |
| 5 | COMPASS THERAPEUTICS INC | CMPX | 43,466 | $138,220 | 0.40% |
| 6 | ALLAKOS INC | 01671P100 | 17,733 | $77,318 | 0.22% |
| 7 | ELEVATION ONCOLOGY INC | 28623U101 | 21,725 | $33,022 | 0.10% |